Serum fetuin-A concentrations were significantly decreased in COVID-19 patients with pneumonia (217.4 (188.3–248.8) vs. 256.3 (218.9–285.7) μg/mL; p < 0.001, respectively). This evidence concerns the gene AHSG and susceptibility to pneumonia measurement.